First-Ever Cannabis Product Approved for Import Into Mexico, RSHO-X™, On Display as Mexico Families Advocate for Medical Cannabis in Mexico
San Diego, CA – Aug. 12, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® Mexico is sponsoring and exhibiting at the Aug. 12-14 ExpoWeed Conference, the first-ever cannabis conference to be held in Mexico.
In addition, on Aug. 14 at 10:15 a.m. HempMeds® Mexico’s new president Dion Markgraaff will be speaking at the ExpoWeed Conference, which is taking place at the International Exhibitions and Conference World Trade Center in Mexico City. Markgraff will be joined by Mexico’s champion for cannabis reform Raul Elizalde, founder of the Por Grace Foundation, the leading association fighting to ensure families receive the right to health care and medical access to cannabidiol (CBD) hemp oil in Mexico.
The Elizalde family was the first in Mexico to sue the federal government and win the right to import CBD hemp oil to treat their daughter Grace’s severe form of epilepsy, which created the legal precedent for other Mexican families to import Medical Marijuana, Inc.’s Real Scientific Hemp Oil-X (RSHO-X™), including the Maldonado family. The Maldonados became one of the first two families in history to receive a permit from the Mexico government to import RSHO-X™ to treat their 11-year-old daughter Alina’s severe form of epilepsy. Alina’s father Abelardo Maldonado will also speak at the conference about how RSHO-X™ helped his daughter.
“It’s exciting to see how the attitude in Mexico towards medical marijuana is positively evolving, as evident by this first-ever cannabis conference being held in Mexico City,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are proud that our CBD hemp oil was the first-ever product that the Mexico government approved for importation and we will continue advocating for ‘access for all’ on behalf of Mexico residents. We are confident that Mexico’s marijuana policies will continue moving in the right direction away from prohibition and towards science-based policies and human rights and we appreciate families like the Maldonados continually raising awareness.”
HempMeds® Mexico will also be exhibiting retail-ready cannabis products at the ExpoWeed Conference, including its zero-THC RSHO-X™, the first-ever cannabis product to receive approval from the federal government of Mexico for importation. RSHO-X™ is also the first cannabis-based product to qualify as safe for World Anti-Doping standards and therefore could be safely used by Olympic athletes.
Qualifying patients in Mexico interested in accessing RSHO-X™ can start the process on the HempMeds® Mexico website. Outside of Mexico, RSHO-X™ is sold as a supplement to all 50 U.S. states and over 40 countries internationally and can be found online in the Medical Marijuana, Inc. online store.
About HempMeds® Mexico
HempMeds® Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMeds® Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company’s website at: http://www.hempmeds.mx.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500
Email: [email protected]